Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Treatment Resistant Depression
NCT02610712Phase 4Unknown
- Start
- May 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in treatment-resistant depression (TRD). Status: unknown.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT02610712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610712.